Bangladesh vs IDA & IBRD total: Immunization, Hib3
Bangladesh
97.0%
in 2024
IDA & IBRD total
75.9%
in 2024
Bangladesh rank
29th
IDA & IBRD total rank
28th
Immunization, Hib3 over time
- Bangladesh
- IDA & IBRD total
How they compare
Bangladesh currently reports 97.0% against 75.9% in IDA & IBRD total, a difference of 21.1%.
That makes Bangladesh's figure about 1.3 times IDA & IBRD total's.
Across all 16 years both countries report, Bangladesh has been ahead every year.
Bangladesh ranks 29th and IDA & IBRD total ranks 28th of 191 countries.
Bangladesh has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Bangladesh | IDA & IBRD total | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 97.0% | 34.0% | 63.0% | Bangladesh |
| 2010s | 95.8% | 54.7% | 41.1% | Bangladesh |
| 2020s | 97.2% | 72.6% | 24.6% | Bangladesh |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher immunization, hib3, Bangladesh or IDA & IBRD total?
- Bangladesh, at 97.0% against 75.9% in IDA & IBRD total as of 2024.
- What is the difference in immunization, hib3 between Bangladesh and IDA & IBRD total?
- 21.1%, with Bangladesh ahead.
- How many years of comparable data are there for Bangladesh and IDA & IBRD total?
- 16 years are reported by both, from 2009 to 2024.
- How do Bangladesh and IDA & IBRD total rank globally for immunization, hib3?
- Bangladesh ranks 29th and IDA & IBRD total ranks 28th of 191 countries.
- Where does this data come from?
- WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/), published as Immunization, Hib3 (% of children ages 12-23 months). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Child immunization, Hib3, measures the percentage of children ages 12-23 months who received Hib3 vaccinations before 12 months or at any time before the survey. A child is considered adequately immunized against Hib3 after receiving three doses of Haemophilus influenzae type b vaccine.